Thursday, October 17, 2024
HomeFinnacial"Financial Synergies buys stake in Allstate (NYSE: ALL)"

“Financial Synergies buys stake in Allstate (NYSE: ALL)”

Several hedge funds and institutional investors have recently adjusted their investments in Allstate. Rise Advisors LLC and Northwest Investment Counselors LLC each bought new shares worth about $26,000 in the first quarter. Versant Capital Management Inc increased its holdings by 70.9%, now owning 188 shares worth $30,000 after buying an additional 78 shares. Family Firm Inc spent $38,000 on new shares in the second quarter, and MCF Advisors LLC raised its stake by 33.9%, now owning 332 shares valued at $53,000. Overall, 76.47% of Allstate’s stock is held by institutional investors.

Allstate Stock Down 4.9%

Allstate’s stock opened at $181.18 recently. The company has a market cap of $47.82 billion and a P/E ratio of 40.00. Its 50-day moving average is $183.18, and its 52-week range is between $112.42 and $193.97.

Allstate reported earnings of $1.61 per share for the quarter ending July 31, significantly beating analysts expectations of $0.33. Revenue was $15.71 billion, exceeding forecasts of $14.04 billion, and showed a year-over-year increase of 12.4%. Analysts predict earnings of $15.2 per share for the current fiscal year.

Allstate Announces Dividend

Allstate recently paid a quarterly dividend of $0.92 per share on October 1. The annualized dividend is $3.68, yielding 2.03%, with a dividend payout ratio of 81.24%.

Insider Activity at Allstate

Insider John E. Dugenske sold 36,367 shares for approximately $6.96 million on September 20. After the sale, he still holds 27,364 shares worth about $5.24 million. Another executive, Robert Toohey, sold 16,682 shares for about $3 million. Overall, insiders sold 238,305 shares valued at $43.08 million in the last 90 days, holding 1.80% of the company’s stock.

Analyst Ratings Changes

Analysts are closely watching Allstate. Morgan Stanley lowered its price target from $205 to $200 but maintains an “overweight” rating. Raymond James raised its target from $205 to $220, giving it a “strong-buy” rating. Overall, analysts rate Allstate as a “Moderate Buy” with a consensus target price of $195.12.

Read Our Latest Stock Analysis on Allstate

About Allstate

Allstate Corporation provides insurance products across the U.S. and Canada, operating in various segments, including property and casualty and health benefits.

See Also

Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com for the latest on Allstate Co. (NYSE:ALL).

Institutional Ownership by Quarter for Allstate (NYSE:ALL)

Receive News & Ratings for Allstate Daily – Enter your email below for a free daily summary of the latest news and analyst ratings for Allstate.




RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisment -

Most Popular

Recent Comments